CAS: 649735-46-6 - (2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol
Formula:C19H19FN4O3
InChI:InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1
InChI key:InChIKey=WCWUXEGQKLTGDX-LLVKDONJSA-N
SMILES:FC1=C(OC2=NC=NN3C=C(OCC(O)C)C(=C23)C)C=CC=4NC(=CC14)C
- Synonyms:
- (2R)-1-[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-ol
- (2R)-1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol
- 2-Propanol, 1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-, (2R)-
- Bms-540215
- Brivanib
- Ptk787
- Vatalanib
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol REF: IN-DA00ECCZCAS: 649735-46-6 | 96% | 64.00 €~492.00 € | Tue 07 Jan 25 | |
Brivanib REF: TM-T6036CAS: 649735-46-6 | 98.87% | 46.00 €~804.00 € | Wed 08 Jan 25 | |
BMS-540215 REF: 7W-GW5097CAS: 649735-46-6 | - - - | 265.00 €~713.00 € | Tue 14 Jan 25 | |
Brivanib REF: 3D-FB103852CAS: 649735-46-6 | Min. 95% | - - - | Discontinued product |
1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol
CAS:649735-46-6
Formula:
C19H19FN4O3
Purity:
96%
Color and Shape:
Solid
Molecular weight:
370.3776
Ref: IN-DA00ECCZ
5mg | 64.00 € | ||
25mg | 137.00 € | ||
50mg | 164.00 € | ||
100mg | 275.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Brivanib
CAS:649735-46-6
Brivanib (BMS-540215) is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate potency …
Formula:
C19H19FN4O3
Purity:
98.87%
Color and Shape:
Solid
Molecular weight:
370.38
Ref: TM-T6036
1mg | 46.00 € | ||
5mg | 88.00 € | ||
10mg | 143.00 € | ||
25mg | 256.00 € | ||
50mg | 371.00 € | ||
100mg | 553.00 € | ||
200mg | 804.00 € | ||
1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: 7W-GW5097
1mg | 265.00 € | ||
5mg | 383.00 € | ||
10mg | 713.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Brivanib
CAS:649735-46-6
Brivanib is a drug that belongs to the class of inhibitors. It was developed as …
Formula:
C19H19FN4O3
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
370.38 g/mol
Ref: 3D-FB103852
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |